The Glucagon‐like peptide‐1 receptor agonist, exendin‐4, ameliorated gastrointestinal dysfunction in the Wistar Kyoto rat model of Irritable Bowel Syndrome-Reference-Cited by-同舟云学术

The Glucagon‐like peptide‐1 receptor agonist, exendin‐4, ameliorated gastrointestinal dysfunction in the Wistar Kyoto rat model of Irritable Bowel Syndrome

Published:2019-10-11 Issue:2 Volume:32 Page:
ISSN:1350-1925
Container-title:Neurogastroenterology & Motility
language:en
Short-container-title:Neurogastroenterology & Motility

Author:

O’Brien Rebecca¹,O’Malley Dervla¹²^ORCID

Affiliation:

1. Department of Physiology University College Cork Cork Ireland

2. APC Microbiome Ireland University College Cork Cork Ireland

Publisher

Wiley

Subject

Gastroenterology,Endocrine and Autonomic Systems,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nmo.13738

Reference58 articles.

1. Functional Bowel Disorders

2. The Gut-Brain Axis and the Microbiome: Clues to Pathophysiology and Opportunities for Novel Management Strategies in Irritable Bowel Syndrome (IBS)

3. The Intestinal Microenvironment and Functional Gastrointestinal Disorders

4. Irritable bowel syndrome

5. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review;The Journal of Headache and Pain;2024-07-12

2. Inhibition of calcium-sensing receptor by its antagonist promotes gastrointestinal motility in a Parkinson’s disease mouse model;Biomedicine & Pharmacotherapy;2024-05

3. Centrally administered GLP-1 analogue improves intestinal barrier function through the brain orexin and the vagal pathway in rats;Brain Research;2023-06

4. Involvement of enteric glial cells in colonic motility in a rat model of irritable bowel syndrome with predominant diarrhea;Journal of Chemical Neuroanatomy;2023-03

5. Involvement of Intestinal Enteroendocrine Cells in Neurological and Psychiatric Disorders;Biomedicines;2022-10-14